Studies of Antiviral Activity and Cytotoxicity of Sphaeranthus indicus and Coldenia procumbens
DOI:
https://doi.org/10.12300/rrjopc.v5i2.126Abstract
The presence of drug-resistant Human Immuno+deficiency Virus (HIV) is a major global concern and warrants the development of novel antivirals as alternative and inexpensive therapy. In the current study, previously unreported antiviral activity of aqueous extracts of two indigenous plants used in Ayurveda in India, such as Sphaeranthus indicus and Coldenia procumbens, against replication of HIV-1 (III B) and HIV-2 (Rod) in MT-4 cells was assigned. These extracts tested were relatively nontoxic to human lymphocytic MT-4 cells; these extracts exhibited anti-HIV activity in an in vitro MTT assay. The aqueous extract of S. indicus inhibited the HIV-1 replication at IC50 of 52.35 µg/ml, whereas this extract does not inhibit the HIV-2 replication in MT-4 cells. No cytotoxicity was observed at 125 µg/ml. The maximum inhibition of this extract is 110.5%. The aqueous extract of C. procumbens inhibited both HIV-1 and HIV-2 replication at comparable IC50 values, namely 32.10 and 41.60, respectively. No cytotoxicity was observed at 125 µg/ml. The maximum inhibition of this extract in HIV-1 replication is 141% and HIV-2 replication is 114.5%. The above results showed that aqueous extract of C. procumbens had more potent anti-HIV activity than S. indicus. In this study, the aqueous extracts of S. indicus and C. procumbens showed antiviral properties that may be useful in the treatment of patients with AIDS.
Keywords: Anti-HIV activity, aqueous extracts, Sphaeranthus indicus, Coldenia procumbens
Cite this Article
Venkatachalam D, Kumar SKP, Middha A. Studies of Antiviral Activity and Cytotoxicity of Sphaeranthus indicus and Coldenia procumbens. Research & Reviews: A Journal of Pharmacognosy. 2018; 5(2): 15–20p.
Downloads
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |